ES2076085B1 - Antagonistas de angiotensina ii. - Google Patents

Antagonistas de angiotensina ii.

Info

Publication number
ES2076085B1
ES2076085B1 ES9301321A ES9301321A ES2076085B1 ES 2076085 B1 ES2076085 B1 ES 2076085B1 ES 9301321 A ES9301321 A ES 9301321A ES 9301321 A ES9301321 A ES 9301321A ES 2076085 B1 ES2076085 B1 ES 2076085B1
Authority
ES
Spain
Prior art keywords
angiotensin
antagonists
formula
provides
famaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9301321A
Other languages
English (en)
Other versions
ES2076085A1 (es
Inventor
Donald Bradford Boyd
Kenneth Lee Hauser
Sherryl Lynn Lifer
Winston Stanley Marshall
Alan David Palkowitz
William Pfeifer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to ES9301321A priority Critical patent/ES2076085B1/es
Publication of ES2076085A1 publication Critical patent/ES2076085A1/es
Application granted granted Critical
Publication of ES2076085B1 publication Critical patent/ES2076085B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ANTAGONISTAS DE ANGIOTENSINA II. LA INVENCION PROPORCIONA COMPUESTOS DE FORMULA (I) QUE ANTAGONIZA LA ANGIOTENSINA II EN LOS SITIOS RECEPTORES DEL CUERPO. TAMBIEN PROPORCIONA FORMULACIONES FARMACEUTICAS QUE COMPRENDEN UN COMPUESTO DE FORMULA I JUNTO CON UNO O MAS EXCIPIENTES ACEPTABLES FAMACEUTICAMENTE, VEHICULOS O DILUYENTES. TIENE APLICACION EN EL TRATAMIENTO DE LA HIPERTENSION, FALLO CARDIACO CONGESTIVO, INSUFICIENCIAS RENALES Y GLAUCOMA, ASI COMO EN LA MEJORA DEL RENDIMIENTO COGNITIVO.
ES9301321A 1993-06-15 1993-06-15 Antagonistas de angiotensina ii. Expired - Fee Related ES2076085B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301321A ES2076085B1 (es) 1993-06-15 1993-06-15 Antagonistas de angiotensina ii.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301321A ES2076085B1 (es) 1993-06-15 1993-06-15 Antagonistas de angiotensina ii.

Publications (2)

Publication Number Publication Date
ES2076085A1 ES2076085A1 (es) 1995-10-16
ES2076085B1 true ES2076085B1 (es) 1997-03-01

Family

ID=8282194

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301321A Expired - Fee Related ES2076085B1 (es) 1993-06-15 1993-06-15 Antagonistas de angiotensina ii.

Country Status (1)

Country Link
ES (1) ES2076085B1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists

Also Published As

Publication number Publication date
ES2076085A1 (es) 1995-10-16

Similar Documents

Publication Publication Date Title
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
DE60214392D1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
ID26984A (id) Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
AU626699B2 (en) Substituted quinazolinones as angiotensin ii antagonists
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
MY126559A (en) Fungicidal 2-methoxybenzophenones
UY26482A1 (es) Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
DK1413582T3 (da) Dimere pyrrolobenzodiazepiner
BR0112030A (pt) Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor
ATE449081T1 (de) Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
EA200400284A1 (ru) Антинеопластические комбинации
ES2195970T3 (es) L-ribavirina y usos de la misma.
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
DE69903333D1 (de) Crf rezeptor-antagonisten und darauf bezogene methoden
UY27208A1 (es) Una combinación que comprende combretastatina y agentes anticarcinógenos.
EA200201158A1 (ru) Бициклические циклогексиламины и их применение в качестве антагонистов nmda-рецепторов
ES2171911T3 (es) Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.
PA8577601A1 (es) Derivados aldehido de polietilenglicol
CO4750755A1 (es) Mezla sinergica de un compuesto arilo o heteroarilo que inhibe la respiracion del complejo citocromo y 4-tert- butilfenilquinazolin-4il eter
DE60112574D1 (de) Bicyclische cyclohexylamine und ihre verwendung als nmda-rezeptor antagonisten
ES2152328T3 (es) Antagonistas del receptor del fibrinogeno.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19930615

Kind code of ref document: B1

Effective date: 19930615

FD1A Patent lapsed

Effective date: 20040503